Sigalov AB. Biochimie. 2022
Category: Publication
Triggering receptor expressed on myeloid cells-1 (TREM-1) contributes to Bordetella pertussis inflammatory pathology
Gallop D, Scanlon K et al. Infect Immun. 2021
SCHOOL of nature: ligand-independent immunomodulatory peptides
Sigalov AB. Drug Discovery Today. 2020
Inhibition of Triggering Receptor Expressed on Myeloid Cells 1 Ameliorates Inflammation and Macrophage and Neutrophil Activation in Alcoholic Liver Disease in Mice
Tornai D, Furi I et al. Hepatol Commun. 2019
Bulk and Single-Cell Profiling of Breast Tumors Identifies TREM-1 as a Dominant Immune Suppressive Marker Associated With Poor Outcomes
Pullikuth et al. Front Oncol. 2021
Commentary: Triggering Receptor Expressed on Myeloid Cells-1 Inhibitor Targeted to Endothelium Decreases Cell Activation
Sigalov AB. Front Immunol. 2020
Targeting Tumor-Associated Macrophages to Radiosensitize Glioblastoma in a Mouse Model
Mark DJ, Ruggieri M et al. Int J Radiat Oncol Biol Phys. 2019
Novel TREM-1 Inhibitors Attenuate Tumor Growth and Prolong Survival in Experimental Pancreatic Cancer
Shen ZT and Sigalov AB. Mol Pharm. 2017
